...
首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Integrated Chinese Herbal Medicine and Western Medicine on the Survival in Patients with Colorectal Cancer: A Retrospective Study of Medical Records
【24h】

Integrated Chinese Herbal Medicine and Western Medicine on the Survival in Patients with Colorectal Cancer: A Retrospective Study of Medical Records

机译:中草药和西医结直肠癌患者的生存:医疗记录的回顾性研究

获取原文

摘要

Recent studies suggested that Traditional Chinese Medicine could play a beneficial role in conventional cancer treatment. The aim of this retrospective cohort study was to investigate the effect of Chinese herbal medicine (CHM) combined with Western medicine on the survival of patients with colorectal cancer. A retrospective cohort study was conducted on patients with newly diagnosed colorectal cancer identified from the Dalin Tzu Chi Hospital Cancer Registry Database in 2004–2014. Combining with the medical records of the study hospital, patients were classified into CHM users and CHM nonusers. Kaplan–Meier analyses and Cox proportional hazards regression analyses were used to investigate the survival between CHM users and CHM nonusers. A total of 535 patients with colorectal cancer were included in the study with 147 of them were CHM users. The log-rank test for Kaplan–Meier survival curve revealed a statistically significant difference between the survival of CHM users and CHM nonusers (P=0.006). Results from multivariate Cox regression analysis showed that CHM use was significantly associated with better survival (adjusted hazard ratio?=?0.54, 95% CI?=?0.38 to 0.77). In addition, the CHM formulae Jia Wei Xiao Yao San, Zhi Bah Di Huang Wan, Ping Wei San, and Qui Pi Tang were significantly associated with better survival. In conclusion, findings from this retrospective cohort study indicated that integrated CHM and Western medicine could improve survival in patients with colorectal cancer. Additional research on integrating TCM with Western medicine to improve cancer survival is warranted.
机译:最近的研究表明,中药可以在常规癌症治疗中发挥有益作用。该回顾性队列研究的目的是探讨中草药(CHM)与西医结合对结直肠癌患者的生存的影响。对2004 - 2014年达林智志医院癌症注册数据库中发现的新诊断的结直肠癌患者进行了回顾性队列研究。将患者分为CHM用户和CHM NONUSERS与学习医院的医疗记录相结合。 Kaplan-Meier分析和Cox比例危害回归分析用于研究CHM用户与CHM非用户之间的生存。在研究中,共有535例结直肠癌患者,其中147例是CHM用户。 Kaplan-Meier生存曲线的日志秩检验显示CHM用户和CHM NONUSERS的存活之间的统计学显着差异(P = 0.006)。多变量Cox回归分析结果表明,CHM使用与更好的存活率显着相关(调整后的危险比?= 0.54,95%CI?= 0.38至0.77)。此外,CHM Formulas jia Wei Xiao Yao San,Zhi Bah Di Huang Wan,Ping Wei San和Qui Pi唐与更好的生存有显着相关。总之,从该回顾性队列研究中的研究结果表明,集成CHM和西医可以改善结直肠癌患者的存活。有关将中医与西医结合改善癌症生存的额外研究得到了认证。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号